GeneDx Holdings (WGS) Operating Margin (2020 - 2025)
Historic Operating Margin for GeneDx Holdings (WGS) over the last 6 years, with Q3 2025 value amounting to 2.78%.
- GeneDx Holdings' Operating Margin rose 73400.0% to 2.78% in Q3 2025 from the same period last year, while for Sep 2025 it was 2.48%, marking a year-over-year increase of 240600.0%. This contributed to the annual value of 7.6% for FY2024, which is 815500.0% up from last year.
- GeneDx Holdings' Operating Margin amounted to 2.78% in Q3 2025, which was up 73400.0% from 8.73% recorded in Q2 2025.
- In the past 5 years, GeneDx Holdings' Operating Margin registered a high of 9.21% during Q4 2024, and its lowest value of 529.56% during Q4 2022.
- For the 5-year period, GeneDx Holdings' Operating Margin averaged around 129.99%, with its median value being 96.67% (2021).
- In the last 5 years, GeneDx Holdings' Operating Margin crashed by -3530200bps in 2022 and then surged by 4848900bps in 2023.
- Over the past 5 years, GeneDx Holdings' Operating Margin (Quarter) stood at 200.31% in 2021, then crashed by -164bps to 529.56% in 2022, then skyrocketed by 92bps to 44.66% in 2023, then skyrocketed by 121bps to 9.21% in 2024, then tumbled by -130bps to 2.78% in 2025.
- Its Operating Margin stands at 2.78% for Q3 2025, versus 8.73% for Q2 2025 and 5.22% for Q1 2025.